Effect of melphalan 140 mg/m<sup>2</sup> vs 200 mg/m<sup>2</sup> on toxicities and outcomes in multiple myeloma patients undergoing single autologous stem cell transplantation—a single center experience

Lakshmikanth Katragadda(University of Florida), Jan S. Moreb(University of Florida), Lindsay McCullough(University of Florida), Yunfeng Dai(University of Florida), Michael Byrne(Vanderbilt University Medical Center), Christopher R. Cogle(University of Florida), Stratford W. May(University of Florida), Myron Chang(University of Florida Health), Randy A. Brown(University of Florida), John Hiemenz(Moffitt Cancer Center), John R. Wingard(University of Florida Health), Jack W. Hsu(University of Florida Health), Maxim Norkin(Centre Hospitalier Universitaire Vaudois)
Clinical Transplantation
May 25, 2016
Cited by 19


Related Papers